Novo Nordisk A/S (ETR:NOV)
Germany · Delayed Price · Currency is EUR 51.12
+0.40 (0.79%)
Jan 12, 2026, 11:39 AM CET
Novo Nordisk Market Cap
Novo Nordisk has a market cap or net worth of €226.8 billion as of January 12, 2026. Its market cap has decreased by -50.53% in one year.
Market Cap
226.80B
Enterprise Value
235.99B
Revenue
42.26B
Ranking
n/a
PE Ratio
16.32
Stock Price
€51.12
Market Cap Chart
Since February 18, 1997, Novo Nordisk's market cap has increased from 6.23B to 226.80B, an increase of 3,542.40%. That is a compound annual growth rate of 13.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 226.80B | 17.20% |
| Dec 30, 2025 | 193.51B | -47.96% |
| Dec 30, 2024 | 371.85B | -10.95% |
| Dec 29, 2023 | 417.56B | 46.59% |
| Dec 30, 2022 | 284.85B | 26.44% |
| Dec 30, 2021 | 225.29B | 69.93% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 55.78B |
| Siemens Healthineers AG | 51.89B |
| Bayer Aktiengesellschaft | 38.20B |
| Fresenius SE & Co. KGaA | 27.73B |
| Sartorius Aktiengesellschaft | 15.77B |
| Fresenius Medical Care AG | 11.04B |
| Fielmann Group AG | 3.67B |
| Carl Zeiss Meditec AG | 3.61B |